Cancer Research Center Groningen (CRCG)

University of Groningen > Faculteit Medische Wetenschappen/UMCG > Cancer Research Center Groningen (CRCG)

  1. 2020
  2. GEOMETRY Mono-1, Wolf, J., Seto, T., Han, J-Y., Reguart, N., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Hida, T., de Jonge, M., Orlov, S. V., Smit, E. F., Souquet, P-J., Vansteenkiste, J., Hochmair, M., Felip, E., Nishio, M., Thomas, M., Ohashi, K., ... Heist, R. S. (2020). Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. New England Journal of Medicine, 383(10), 944-957. https://doi.org/10.1056/NEJMoa2002787
  3. Aliee, H., Massip, F., Qi, C., Stella de Biase, M., van Nijnatten, J. L., Kersten, E. T. G., Kermani, N. Z., Khuder, B., Vonk, J. M., Vermeulen, R. C. H., Neighbors, M., Tew, G. W., Grimbaldeston, M., Ten Hacken, N. H. T., Hu, S., Guo, Y., Zhang, X., Sun, K., Hiemstra, P. S., ... Faiz, A. (2020). Determinants of SARS-CoV-2 receptor gene expression in upper and lower airways. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2020.08.31.20169946
  4. van Dellen, E., Borner, C., Schutte, M., van Montfort, S., Abramovic, L., Boks, M. P., Cahn, W., van Haren, N., Mandl, R., Stam, C. J., & Sommer, I. (2020). Functional brain networks in the schizophrenia spectrum and bipolar disorder with psychosis. NPJ Schizophrenia, 6(1), [22]. https://doi.org/10.1038/s41537-020-00111-6
  5. Reumkens, K., Tummers, M. H. E., Severijns, Y., Gietel-Habets, J. J. G., van Kuijk, S. M. J., Aalfs, C. M., van Asperen, C. J., Ausems, M. G. E. M., Collee, M., Dommering, C. J., Kets, M., van der Kolk, L. E., Oosterwijk, J. C., Tjan-Heijnen, V. C. G., van der Weijden, T., de Die-Smulders, C. E. M., & van Osch, L. A. D. M. (2020). Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making. Journal of community genetics. https://doi.org/10.1007/s12687-020-00484-2
  6. van Santen, H. M., Alexander, E. K., Rivkees, S. A., Frey, E., Clement, S. C., Dierselhuis, M. P., Lebbink, C. A., Links, T. P., Lorenz, K., Peeters, R. P., Reiners, C., Vriens, M. R., Nathan, P., Schneider, A. B., & Verburg, F. (2020). Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors. European Journal of Endocrinology, 183(3), P1-P10. https://doi.org/10.1530/EJE-20-0237
  7. van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., & Menke-van der Houven van Oordt, C. W. (2020). Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging, 47(10), 2481-2481. https://doi.org/10.1007/s00259-020-04908-6
  8. Familial MRI Screening (FaMRIsc) Study group, Geuzinge, H. A., Obdeijn, I-M., Rutgers, E. J. T., Saadatmand, S., Mann, R. M., Oosterwijk, J. C., Tollenaar, R. A. E. M., de Roy van Zuidewijn, D. B. W., Lobbes, M. B. I., van 't Riet, M., Hooning, M. J., Ausems, M. G. E. M., Loo, C. E., Wesseling, J., Luiten, E. J. T., Zonderland, H. M., Verhoef, C., Heijnsdijk, E. A. M., ... de Koning, H. J. (2020). Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. JAMA oncology, 6(9), 1381-1389. https://doi.org/10.1001/jamaoncol.2020.2922
  9. Gelderblom, H., Gietema, J. A., Desar, I. M. E., Ajmone, N. M., Jalving, M., Kroep, J. R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S. F., & Damstrup, L. (2020). First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. Annals of Oncology, 31, S501-S502. https://doi.org/10.1016/j.annonc.2020.08.715
  10. Dutch Hyperparathyroidism Study Group, Koh, E. Y., van der Plas, W. Y., Dulfer, R. R., Pol, R. A., Kruijf, S., Rotmans, J. I., Appelman-Dijkstra, N., Schepers, A., de Borst, M. H., Hoorn, E. J., van Ginhoven, T., Nieveen van Dijkum, E. J. M., Vogt, L., & Engelsman, A. F. (2020). Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis. Langenbecks Archives of Surgery, 405(6), 851-859. https://doi.org/10.1007/s00423-020-01953-5
  11. van Zeijl, M. C. T., Boer, F. L., van Poelgeest, M. I. E., van den Eertwegh, A. J. M., Wouters, M. W. J. M., de Wreede, L. C., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Boers-Sonderen, M. J., Kapiteijn, E. H. W., & Haanen, J. B. A. G. (2020). Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based study. European Journal of Cancer, 137, 127-135. https://doi.org/10.1016/j.ejca.2020.05.021
  12. Versluis, J. M., Hendriks, A. M., Weppler, A., Brown, L., de Joode, K., Suijkerbuijk, K. P. M., Zimmer, L., Kapiteijn, E., Allayous, C., Johnson, D. B., Hepner, A., Mangana, J., Bhave, P., Jansen, Y., Trojaniello, C., Atkinson, V., Storey, L., de Vries, E. G. E., Blank, C. U., & Jalving, M. (2020). The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition. Annals of Oncology, 31, S733-S734. https://doi.org/10.1016/j.annonc.2020.08.1204
  13. Joode, K. D., Groen, H. J. M., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., de Groot, J. W. B., de Wijn, R., Hurkmans, D. P., van den Heuvel, D. M. A., Schmidt, K., Groten, J. P., Verdegaal, E. M. E., van der Burg, S. H., van den Heuvel, M. M., Aerts, J. G. J. V., Kapiteijn, E., & Mathijssen, R. H. (2020). Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC. Annals of Oncology, 31, S788-S788. https://doi.org/10.1016/j.annonc.2020.08.094
  14. Marsh, E. K., Prestwich, E. C., Williams, L., Hart, A. R., Muir, C. F., Parker, L. C., Jonker, M. R., Heijink, I. H., Timens, W., Fife, M., Hussell, T., Hershenson, M. B., Bentley, J. K., Sun, S-C., Barksby, B. S., Borthwick, L. A., Stewart, J. P., Sabroe, I., Dockrell, D. H., & Marriott, H. M. (2020). Pellino-1 Regulates the Responses of the Airway to Viral Infection. Frontiers in Cellular and Infection Microbiology, 10, [456]. https://doi.org/10.3389/fcimb.2020.00456
  15. Benedict, B., van Bueren, M. A., van Gemert, F. P., Lieftink, C., Guerrero Llobet, S., van Vugt, M. A., Beijersbergen, R. L., & Te Riele, H. (2020). The RECQL helicase prevents replication fork collapse during replication stress. Life science alliance, 3(10), [e202000668]. https://doi.org/10.26508/lsa.202000668
  16. Szulcek, R., Sanchez-Duffhues, G., Rol, N., Pan, X., Tsonaka, R., Dickhoff, C., Yung, L. M., Manz, X. D., Kurakula, K., Kiełbasa, S. M., Mei, H., Timens, W., Yu, P. B., Bogaard, H-J., & Goumans, M-J. (2020). Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells. Angiogenesis, 23(4), 699-714. https://doi.org/10.1007/s10456-020-09741-x
Previous 1 2 3 4 5 6 7 8 ...186 Next

ID: 12296270